Stakeholder perception of quality management of investigator-initiated clinical trials.

Li W, Ailimu K, Jia N, Chu H, Zhao Y, Tao L, Zhan S, Zeng L

Open source

DOI
10.1186/s12910-025-01354-7
Published
2025 Dec 30
Container
BMC medical ethics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12910-025-01354-7,
  title = {Stakeholder perception of quality management of investigator-initiated clinical trials.},
  author = {Li W and Ailimu K and Jia N and Chu H and Zhao Y and Tao L and Zhan S and Zeng L},
  year = {2025},
  journal = {BMC medical ethics},
  doi = {10.1186/s12910-025-01354-7},
  url = {https://doi.org/10.1186/s12910-025-01354-7}
}

RIS

TY  - JOUR
TI  - Stakeholder perception of quality management of investigator-initiated clinical trials.
AU  - Li W
AU  - Ailimu K
AU  - Jia N
AU  - Chu H
AU  - Zhao Y
AU  - Tao L
AU  - Zhan S
AU  - Zeng L
PY  - 2025
JO  - BMC medical ethics
DO  - 10.1186/s12910-025-01354-7
UR  - https://doi.org/10.1186/s12910-025-01354-7
ER  - 

APA

W, L., K, A., N, J., H, C., Y, Z., L, T., S, Z., & L, Z. (2025). Stakeholder perception of quality management of investigator-initiated clinical trials.. BMC medical ethics. https://doi.org/10.1186/s12910-025-01354-7

Source records